Dr. Adly Thebaud

Psychiatry
2725 Rebecca Ln, Ste 107, 
Orange City, FL 
Accepting New Patients
Offers Telehealth
2725 Rebecca Ln, Ste 107, 
Orange City, FL 

Overview

Adly Thebaud is a Psychiatrist practicing medicine in Orange City, Florida.

His clinical expertise encompasses Bipolar Disorder (BPD) and Alzheimer's Disease.

He is actively involved in clinical research, participating in 7 clinical trials. Dr. Thebaud is currently accepting new patients.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in FL

Languages Spoken

English
French
Haitian
Haitian Creole

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Florida Health
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Family Psychiatry Services
2725 Rebecca Ln, Ste 107, Orange City, FL 32763

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Longitudinal Cohort Study of Resource Use and Cost of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in the United States (GERAS-US)
Longitudinal Cohort Study of Resource Use and Cost of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in the United States (GERAS-US)
Enrollment Status: Active_not_recruiting
Publish Date: October 24, 2025
Intervention Type: Drug
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 22, 2025
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 3
An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents
An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents
Enrollment Status: Terminated
Publish Date: May 09, 2024
Intervention Type: Drug
Study Drug: NaBen®
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects
Enrollment Status: Completed
Publish Date: December 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
3
conditions
Expertise in
3
conditions
Referral may be required

APILAX Medical PLLC

25 Laguna Forest Trail, 
Palm Coast, FL 
 (38.0 miles away)
240-422-4953
Experience:
26+ years
Languages Spoken:
English, Russian
Accepting New Patients
Offers Telehealth

Andrei Pikalov is a Psychiatrist practicing medicine in Palm Coast, Florida. He has been practicing medicine for over 26 years. Dr. Pikalov is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Bipolar Disorder (BPD), Schizophrenia, and Major Depression. Dr. Pikalov is board certified in ABPN: Americal Board Of Psychiatry And Neurology. Dr. Pikalov is currently accepting new patients.

Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required

Balanced Wellbeing LLC

3200 Sw 34th Ave, Suite 701, 
Ocala, FL 
 (56.2 miles away)
877-779-2429
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Parikshit Deshmukh is a Psychiatrist practicing medicine in Ocala, Florida. Dr. Deshmukh is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Seasonal Affective Disorder (SAD), Major Depression, Dementia, and Pseudobulbar Affect. Dr. Deshmukh is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Office

804 Dunlawton Ave Unit 1, 
Port Orange, FL 
 (23.7 miles away)
386-767-8584
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Frick is a Psychiatrist practicing medicine in Port Orange, Florida. Dr. Frick is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Seasonal Affective Disorder (SAD), Major Depression, Bipolar Disorder (BPD), and Generalized Anxiety Disorder (GAD). Dr. Frick is currently accepting new patients.

Frequently Asked Questions about Dr. Adly Thebaud

How do I make an appointment with Dr. Adly Thebaud?

You can book an appointment with Dr. Adly Thebaud by calling their office at 386-775-7036. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Adly Thebaud a top-rated expert for Bipolar Disorder (BPD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Adly Thebaud is classified as an Experienced expert for Bipolar Disorder (BPD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Adly Thebaud specialize in?

While Dr. Adly Thebaud is a Psychiatry, they have specific expertise in Bipolar Disorder (BPD), Alzheimer's Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Adly Thebaud accept my insurance?

Dr. Adly Thebaud accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 386-775-7036 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thebaud's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile